RedChip Announces Termination of Relationship With Weikang Bio-Technology

NBC News Clone summarizes the latest on: Wbna43006713 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.

ORLANDO, Fla., May 12, 2011 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international, small-cap research and financial public relations firm, today announced that it has terminated its investor relations agreement with Weikang Bio-Technology Group Co., Inc. ("Weikang").

ORLANDO, Fla., May 12, 2011 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international, small-cap research and financial public relations firm, today announced that it has terminated its investor relations agreement with Weikang Bio-Technology Group Co., Inc. ("Weikang").

On May 12, 2011, RedChip provided notice of termination to Weikang, effective immediately. The termination was based primarily on the fact that officers of Weikang did not make themselves available to RedChip analysts.

About RedChip Companies, Inc.

RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Beijing, China and Seoul, Korea. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research™, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV™, Shareholder Intelligence, Social Media and Blogging Services, Webcasts, and RedChip Radio™. To learn more about RedChip's products and services, please visit: .

The RedChip Companies, Inc. logo is available at

"Discovering Tomorrow's Blue Chips Today"™

CONTACT: Jon Cunningham RedChip Companies, Inc. Tel: 1-800-RED-CHIP (733-2447), Ext. 107 Email: [email protected]

×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone